Financial institutions (Morgan Stanley, BofA, Norges Bank, Millennium Management) made various market moves and issued research notes regarding Acadia Pharmaceuticals.

The entities involved

• Morgan Stanley →

  U.S. investment bank

  • A peace deal is discussed, with terms constraining Israel's objectives and aiming to reopen the Strait of Hormuz.10:02
  • MarketBeat, Morgan Stanley, and Citigroup provided recent stock rating data for Geberit.07:26
• Acadia Pharmaceuticals →

  Pharmaceutical company, which developed Nuplazid, based in San Diego, California.

  • Acadia Pharmaceuticals and C4 Therapeutics, Inc. are being compared as healthcare companies.Mon 15:49
• Millennium Management →

  alternative investment management firm

  • Millennium Management, specializing in Japanese government bonds, faced adverse strategy impacts due to yen rate volatility and filed regulatory records with the Monetary Authority of Singapore.Thu 06:30
• Bank of America →

  American multinational banking and financial services corporation

  • Bank of America initiated coverage and reduced price targets for Pershing Square stock.08:55
  • Financial discussions regarding margin pressures and growth involving United Rentals, Grace, Credit Suisse, and Bank of America.05:00

Related events

• Morgan Stanley and Carlyle Group released research reports and price targets for a company whose stock trades on the Nasdaq platform.Jun 7
• Morgan Stanley and Eagle Point Credit are being compared as finance companies.05:20
• Bank of America, Raymond James Financial, and Citigroup issued rating updates and coverage on AxoGen shares.Oct 13
• Both Morgan Stanley and State Street are identified as major financial institutions.Oct 14
• Citigroup and Bank of America issued rating updates for Acadia Pharmaceuticals, alongside insider news regarding James Kihara.Jun 29